1-3 of 3
Tiemo Joerg Bandel
Close
Sort by
Journal Articles

Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4

Alexander GG Turpie, MD, Kenneth A. Bauer, MD, Bruce Davidson, MD, Michael Gent, MD, Louis Kwong, MD, Michael Rud Lassen, MD, Fred Cushner, MD, Paul Lotke, MD, Scott D. Berkowitz, MD, FACP, Tiemo Joerg Bandel, Frank Misselwitz, MD, William Fisher, MD
Journal: Blood
Blood (2008) 112 (11): 35.
https://doi.org/10.1182/blood.V112.11.35.35
Published: 2008
Journal Articles

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding

Alexander GG Turpie, MD, Michael Rud Lassen, MD, Ajay K Kakkar, PhD, Bengt Eriksson, MD, PhD, Frank Misselwitz, MD, Tiemo Joerg Bandel, MD, Martin Homering, Torsten Westermeier, PhD, Michael Gent, DSc
Journal: Blood
Blood (2008) 112 (11): 36.
https://doi.org/10.1182/blood.V112.11.36.36
Published: 2008
Journal Articles

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effects of Specified Co-Medications.

Bengt Eriksson, MD, Alexander GG Turpie, MD, Michael Rud Lassen, MD, Ajay K Kakkar, PhD, Frank Misselwitz, MD, Tiemo Joerg Bandel, Martin Homering, Torsten Westermeier, Michael Gent, MD
Journal: Blood
Blood (2008) 112 (11): 1986.
https://doi.org/10.1182/blood.V112.11.1986.1986
Published: 2008